Novavax receives EU authorisation for updated COVID vaccine targeting the JN.1 strain

European Commission authorises Novavax The company said Wednesday it has updated its COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region. The authorisation applies to people aged 12 years and older.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO